Impact BioMedical, Inc. (IBO) financials · rev $32.0K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Impact BioMedical, Inc. (IBO) rev $32.0K.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $32.0K | N/A |
| Cost of Revenue | $424.0K | N/A |
| Gross Profit | -$392.0K | N/A |
| Operating Income | -$4.28M | -$28.8M |
| Net Income | -$11.8M | -$24.7M |
| EPS (Diluted) | -$0.38 | -$2.30 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $17.4M | $20.3M |
| Current Assets | $411.0K | $2.45M |
| Cash & Equivalents | $3.00K | $2.00M |
| Inventory | $63.0K | N/A |
| PP&E | N/A | $17.0K |
| Total Liabilities | $1.85M | $13.1M |
| Current Liabilities | $1.16M | $9.79M |
| Shareholders' Equity | $12.6M | $4.26M |
| Retained Earnings | -$49.5M | -$37.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$1.89M | -$3.92M |
| Investing Cash Flow | $3.00K | $2.00K |
| Financing Cash Flow | -$109.0K | $5.92M |
| Net Change in Cash | -$2.00M | $2.00M |
FAQ
What is IBO P/E and revenue?
Impact BioMedical, Inc. (IBO) rev $32.0K.
What is IBO revenue?
Impact BioMedical, Inc. last cached revenue is $32.0K (FY2025).
Is IBO profitable?
Impact BioMedical, Inc. last cached net income is -$11.8M (FY2025).
What are IBO total assets?
Impact BioMedical, Inc. last cached total assets are $17.4M (FY2025).
What is IBO free cash flow?
No cached cash-flow row for IBO yet.
Not investment advice. Cached statements, not a live tape.